1. A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T‐cell lymphomas. (8th August 2013) Authors: Evens, Andrew M.; Rosen, Steven T.; Helenowski, Irene; Kline, Justin; Larsen, Annette; Colvin, Jennifer; Winter, Jane N.; van Besien, Koen M.; Gordon, Leo I.; Smith, Sonali M. Journal: British journal of haematology Issue: Volume 163:Number 1(2013:Oct.) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗